Skip to content

Effects of different intensity of extracorporeal shock wave therapy on upper limb spasticity in stroke patients: a randomized crossover study

Effects of different intensity of extracorporeal shock wave therapy on upper limb spasticity in stroke patients: a randomized crossover study - Effects of different intensity of extracorporeal shock wave therapy on spasticity in stroke patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051374
Enrollment
18
Registered
2023-06-18
Start date
2021-04-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

3,200 shots (1,500 shots to the forearm flexor muscle group) and 800 shots to each interphalangeal muscle of radial extracorporeal shockwave therapy, for a total of 4,700 shots at an intensity of 2.5
3,200 shots (1,500 shots to the forearm flexor muscle group) and 800 shots to each interphalangeal muscle of radial extracorporeal shockwave therapy, for a total of 4,700 shots at an intensity of 1 Ba

Sponsors

Nishiyamato Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. the first occurrence of stroke which resulted in unilateral hemiparesis 2. the modified Ashworth scale for the radiocarpal joint >=1 3. at least 12 month of stroke onset 4. the passive range of wrist joint was between 20 palmar flexion and 30 degrees of dorsiflexion

Exclusion criteria

Exclusion criteria: 1. medically unstable 2. receiving muscle relaxant or anti-spastic medication 3. infraction at the cerebellum region 4. cognitive dysfunction as assessed by Hasegawa's Dementia Scale-Revised (score >20) 5. upper limb fracture or non-muscle spasm related restriction of joint movement 6. pacemaker implantation 7. coagulation disorders 8. deep vein thrombosis 9. tumour disease 10.pregnant woman 11. history of seizures and epilepsy 12. skin lesion of the upper extremity

Design outcomes

Primary

MeasureTime frame
modified Tardieu scale, modified Ashworth scale; Measured before, immediately after, one week, two weeks, three weeks and four weeks after stimulation, respectively

Secondary

MeasureTime frame
pain(Visual Analog Scale); immediately after stimulation

Countries

Japan

Contacts

Public ContactJunji Nakamura

Nishiyamato Rehabilitation Hospital Department of Rehabilitation Medicine

n.junji.0923@gmail.com0745-71-6688

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026